Drug Delivery: Infusion Devices
Drug Delivery: Infusion Devices
$4,750.00
Markets covered by this analysis include the US, Japan, the five major EU markets (France, Germany, Italy, Spain, and the UK), and the Rest of World (RoW) markets, which includes all other countries.
Publisher: Meddevicetracker
- Description
- Contents
OVERVIEW
Markets covered by this analysis include the US, Japan, the five major EU markets (France, Germany, Italy, Spain, and the UK), and the Rest of World (RoW) markets, which includes all other countries. The combined global market for infusion DDT products totaled nearly $9.9bn in 2017, and is expected to climb at a rate of 6.4% over the forecast period. Technological advancements, such as devices with needlestick prevention features and dose error reduction software, are a driver of the infusion DDT market. The largest absolute gains are expected to occur in the insulin pumps segment, which accounts for nearly half of the total infusion products market and is expected to increase at a CAGR of approximately 9.1% over the forecast period. Since the introduction of smart pumps, the formerly flat volumetric pumps market has registered significant gains in dollar volume, driven primarily by the replacement of older volumetric pumps with enhanced-safety, informatics-loaded infusion instruments.
CONTENTS
Executive Summary……………………………………………………………………….. ES-1
i. Infusion devices market………………………………………………………………………………………. ES-1
a. Geographic market analysis ……………………………………………………………………. ES-4
b. Selected market drivers and limiters ……………………………………………………….. ES-6
c. Volumetric pumps segment…………………………………………………………………….. ES-6
d. Syringe pumps segment…………………………………………………………………………. ES-7
e. Ambulatory pumps segment…………………………………………………………………… ES-7
f. Disposable pumps segment …………………………………………………………………….. ES-8
g. Implantable pumps segment…………………………………………………………………… ES-8
h. Insulin pumps segment ………………………………………………………………………….. ES-8
i. Enteral pumps segment…………………………………………………………………………… ES-9
j. Market leaders ………………………………………………………………………………………. ES-9
ii. Methodology ………………………………………………………………………………………………….. ES-10
Exhibit ES-1: Infusion drug delivery systems, combined market forecast, by segment ($m), 2017-22 ………………………………………………………………………….. ES-3
Exhibit ES-2: Infusion drug delivery systems, combined market forecast, by region ($m), 2017-22……………………………………………………………………………… ES-5
1. Infusion Pump Products ……………………………………………………………….1-1
1.1 Volumetric pumps……………………………………………………………………………………………..1-1
1.1.1 Products……………………………………………………………………………………………..1-2
1.2 Syringe pumps…………………………………………………………………………………………………..1-4
1.2.1 Products……………………………………………………………………………………………..1-4
1.3 Ambulatory pumps…………………………………………………………………………………………….1-6
1.3.1 Products……………………………………………………………………………………………..1-6
1.4 Disposable pumps………………………………………………………………………………………………1-8
1.4.1 Products……………………………………………………………………………………………..1-9
1.5 Implantable pumps…………………………………………………………………………………………..1-10
1.5.1 Products……………………………………………………………………………………………1-11
1.6 Insulin pumps ………………………………………………………………………………………………….1-13
1.6.1 Products……………………………………………………………………………………………1-13
1.6.2 Emerging products …………………………………………………………………………….1-19
1.7 Enteral pumps………………………………………………………………………………………………….1-22
1.7.1 Products……………………………………………………………………………………………1-23
1.8 Bibliography…………………………………………………………………………………………………….1-25
Exhibit 1-1: Selected volumetric pumps, 2018…………………………………………………………….1-2
Exhibit 1-2: Selected syringe pumps, 2018………………………………………………………………….1-5
Exhibit 1-3: Selected ambulatory pumps, 2018 …………………………………………………………..1-7
Exhibit 1-4: Selected disposable pumps, 2018…………………………………………………………….1-9
Exhibit 1-5: Selected insulin pumps, 2018…………………………………………………………………1-14
Exhibit 1-6: Selected enteral pumps, 2018………………………………………………………………..1-23
2. Infusion Pumps Market ………………………………………………………………..2-1
2.1 Volumetric pumps market forecast………………………………………………………………………2-4
2.1.1 Competitive analysis…………………………………………………………………………….2-5
2.2 Syringe pumps market forecast……………………………………………………………………………2-8
2.2.1 Competitive analysis…………………………………………………………………………….2-9
2.3 Ambulatory pumps market forecast …………………………………………………………………..2-11
2.3.1 Competitive analysis…………………………………………………………………………..2-13
2.4 Disposable pumps market forecast…………………………………………………………………….2-15
2.4.1 Competitive analysis…………………………………………………………………………..2-17
2.5 Implantable pumps market forecast…………………………………………………………………..2-19
2.6 Insulin pumps market forecast…………………………………………………………………………..2-20
2.6.1 Competitive analysis…………………………………………………………………………..2-23
2.7 Enteral pumps market forecast………………………………………………………………………….2-25
2.7.1 Competitive analysis…………………………………………………………………………..2-27
2.8 Bibliography…………………………………………………………………………………………………….2-30
Exhibit 2-1: Infusion pumps, combined market forecast ($m), 2017-22 …………………………2-3
Exhibit 2-2: Volumetric pumps and disposables, market forecast ($m), 2017-22…………….2-5
Exhibit 2-3: Volumetric pumps and disposables market, share by supplier, 2017 ……………2-7
Exhibit 2-4: Syringe pumps and disposables, market forecast ($m), 2017-22………………….2-9
Exhibit 2-5: Syringe pumps and disposables market, share by supplier, 2017 ……………….2-11
Exhibit 2-6: Ambulatory pumps, market forecast ($m), 2017-22 …………………………………2-13
Exhibit 2-7: Ambulatory pumps and disposables market, share by supplier, 2017 …………2-15
Exhibit 2-8: Disposable infusion pumps, market forecast ($m), 2017-22………………………2-17
Exhibit 2-9: Disposable infusion pumps market, share by supplier, 2017 ……………………..2-19
Exhibit 2-10: Insulin pumps and disposables, market forecast ($m), 2017-22 ……………….2-23
Exhibit 2-11: Insulin pumps and disposables market, share by supplier, 2017 ………………2-25
Exhibit 2-12: Enteral pumps and disposables, market forecast ($m), 2017-22 ………………2-27
Exhibit 2-13: Enteral pumps and disposables market, share by supplier, 2017………………2-29
Appendix: Company Listing……………………………………………………………… A-1
© Informa UK Ltd. This document is a licensed product and is not to be reproduced or redistributed
Do you have a subscription to Datamonitor Healthcare, Biomedtracker or Meddevicetracker? You may already have access to these reports, contact your account manager or email pharma@informabi.com for further help or assistance.
Interventional Cardiology: Atherectomy and Thromboembolectomy 
Sign up to the